Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Protocol
  • Published:

Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later

Abstract

Since its first description 20 years ago, the tetrazolium-based colorimetric (MTT) assay using MT-4 cells for the detection of anti-HIV compounds has been widely used. This method, which remains popular, provides more information than more recently developed methods and, therefore, represents a useful methodology on its own or in combination with other screening systems. The replication of HIV in MT-4 cells is usually monitored 5 d after infection; therefore, this protocol can be divided into three steps: the infection (at day 0), an incubation period (5 d) and the evaluation (at day 5). The long-standing and intensive use of the MTT method has taught users of the limitations and, equally importantly, the unexpected advantages of the MT-4/MTT assay. The use of this method can be extended to antiviral testing of compounds against other cyto-destructive viruses.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Preliminary assessment of the cytotoxicity of DMSO and NMP in MT-4 cells using the MTT/MT-4 assay.
Figure 2: Influence of the amount of viral inoculum on the production of the HIV stock.
Figure 3: Typical examples of results obtained with antiretroviral drugs nevirapine, an NNRTI; AZT, an NRTI and ritonavir, a protease inhibitor.

Similar content being viewed by others

References

  1. Nakashima, H. et al. Tetrazolium-based plaque assay for HIV-1 and HIV-2, and its use in the evaluation of antiviral compounds. J. Virol. Methods 26, 319–329 (1989).

    Article  CAS  PubMed  Google Scholar 

  2. Pauwels, R. et al. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods 20, 309–321 (1988).

    Article  CAS  PubMed  Google Scholar 

  3. Schols, D., Pauwels, R., Vanlangendonck, F., Balzarini, J. & De Clercq, E. A highly reliable, sensitive, flow cytometric/fluorometric assay for the evaluation of the anti-HIV activity of antiviral compounds in MT-4 cells. J. Immunol. Methods 114, 27–32 (1988).

    Article  CAS  PubMed  Google Scholar 

  4. Jordan, A., Bisgrove, D. & Verdin, E. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J. 22, 1868–1877 (2003).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Kutsch, O., Benveniste, E.N., Shaw, G.M. & Levy, D.N. Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency. J. Virol. 76, 8776–8786 (2002).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Kutsch, O. et al. Bis-anthracycline antibiotics inhibit human immunodeficiency virus type 1 transcription. Antimicrob. Agents Chemother. 48, 1652–1663 (2004).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Miyoshi, I. et al. Type-C virus-producing cell-lines derived from adult T-cell leukemia. Gann Monogr. Cancer Res. 219–228 (1982).

  8. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55–63 (1983).

    Article  CAS  PubMed  Google Scholar 

  9. Scudiero, D.A. et al. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48, 4827–4833 (1988).

    CAS  PubMed  Google Scholar 

  10. Roehm, N.W., Rodgers, G.H., Hatfield, S.M. & Glasebrook, A.L. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J. Immunol. Methods 142, 257–265 (1991).

    Article  CAS  PubMed  Google Scholar 

  11. Dunigan, D.D., Waters, S.B. & Owen, T.C. Aqueous soluble tetrazolium/formazan MTS as an indicator of NADH- and NADPH-dependent dehydrogenase activity. Biotechniques 19, 640–649 (1995).

    CAS  PubMed  Google Scholar 

  12. Salahuddin, S.Z. et al. Restricted expression of human T-cell leukemia–lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. Virology 129, 51–64 (1983).

    Article  CAS  PubMed  Google Scholar 

  13. Bjorndal, A. et al. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J. Virol. 71, 7478–7487 (1997).

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Baba, M., Miyake, H., Okamoto, M., Iizawa, Y. & Okonogi, K. Establishment of a CCR5-expressing T-lymphoblastoid cell line highly susceptible to R5 HIV type 1. AIDS Res. Hum. Retroviruses 16, 935–941 (2000).

    Article  CAS  PubMed  Google Scholar 

  15. Reed, L.J. & Muench, H. A simple method for estimating fifty percent endpoints. Am. J. Hyg. 27, 493–497 (1938).

    Google Scholar 

Download references

Acknowledgements

We thank Mrs Kristien Erven for critical reading and fine editorial assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christophe Pannecouque.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pannecouque, C., Daelemans, D. & De Clercq, E. Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later. Nat Protoc 3, 427–434 (2008). https://doi.org/10.1038/nprot.2007.517

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nprot.2007.517

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing